Sunday, November 22, 2020

Why I Still Support President Trump

    When I was evaluating the Republicans in 2016 to decide who to support, I listed my 3 biggest policy areas that were on the platform I wanted.  They were, in order of my priorities:

(1)  A strong military with intelligent, pro-American leadership
(2)  Support of a system of Capitalist Medicine
(3)  Lower taxes and deregulation that would help the economy thrive

President Trump has been very good in (1) & (3), however, I knew even in 2016 that he was not a big proponent of Capitalist Medicine.

Well, yesterday, my worst fears came true.  The President held a news conference that basically said that he is surrendering medicine (not necessarily the practice of the healing arts), but pharmaceuticals, such as medical pills, to a socialist system.

Never in my dreams could I have imagined that America's President Trump would assume point and lead the charge to have the government completely takeover this area of the economy.  It is an area that I know so much about and was hedging my investments with the premise that I could talk Trump out of this communist-style, shutdown of business, which I had seen him hint at before.

So, I've had some sharp words to say about America's Still President-Elect, but what you may not understand is that I continue to support him to be recognized for 4 more years.  Here's why:

The simplest way to describe it is mathematically.  An ideally strong platform holds: (1), (2) & (3).  However, presently, Trump has (1) & (3), against (2).  To illustrate it in political terms; what good does a thriving American medical system do if there is a nuclear war?  And, in support of "the U.S. military outweighs all argument" is a very good economy on top of that.

Paul Wharton
Pro-Trump, but with significant reservations

Saturday, October 24, 2020

A "Dark Winter" With No Fracking

    They say "Sleepy Joe Biden" is a compulsive liar.  However, after watching the final Presidential Debate, I'm inclined to say that Sleepy Joe is right on about one thing.  Biden foresees a "Dark Winter".  But, after President Trump cornered Sleepy Joe into admitting that he wants to eliminate fossil fuels--especially the act of "fracking" to extract them for use, I'd say that next winter could very well be the darkest on record.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Friday, October 9, 2020

Eli Lilly's Antibody Cocktails Could Run Out

    Two days ago, President Trump spoke to the American people from outside the Oval Office about his medical experience in dealing with the Coronavirus.  While he was at Walter Reed Military Hospital, he received two therapeutic antibody cocktails: one from Eli Lilly, and the other from Regeneron.  The therapeutics from those two companies are now set to be approved so those drug companies can market and sell them.

As a blogger for Eli Lilly, I have noticed that in accordance with Trump's wishes for a low-cost medical dose, combined with Eli Lilly's philanthropic tendency, I expect deep discounts in the Lilly cocktail's price.  However, in my coverage of news about the progress of the antibody medicine, I have seen footage of Lilly's CEO speaking about how difficult the antibodies are to produce.  The point I am trying to make is that maybe a high-cost quantity should be held in reserve so that those who have the money to buy the cocktails can do so before the supply runs out.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind
 

Monday, October 5, 2020

This Time It's Personal

    The Chinese government manufactured a biological weapon that has been devastating to many human lives on Earth.  Trump recognizes that and frequently speaks out against China and their "China Virus".  For months, Trump has been isolated from the experience of having to actually, physically deal with the virus.  However, just recently, China's biological weapon finally found it's most strategic mark, when it infected The President of the United States.

It looks like President Trump will recover.  But, that does not bring back lost leadership time and campaign stops that could have added support for the upcoming election.  Trump had been fond of calling out the maker of The China Virus in his news conferences.  I expect that he will bring out the heavy artillery and really go after China now that it has hit so close to home.

So far, President Trump had been responding to China having killed close to 200,000 Americans.  That alone was enough to really get him worked up.  However, this time it's personal.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Wednesday, September 23, 2020

Eli Lilly's New Migraine Medicine

    Eli Lilly & Co. (LLY) reported it's wildly successful data from a Phase 3 trial of it's migraine medicine called Lasmiditan.  Migraines are not an uncommon, debilitating occurrence.  I, myself, went through a period when I was somewhat afflicted with the condition.  In my experience there are three hallmarks of a migraine: head pain, a visual aura, and nausea.  The aura is the strangest aspect of the symptoms.  With me, it involved the interruption of a clear field of vision with what seemed like a waving visual range.  This usually began in a small area of my visual field, and could spread to my whole vision before the migraine receded.  Another symptom is nausea.  When I would get a full-blown migraine, about half the time, it caused me to throw up.  It seems odd that a headache and visual disturbance would cause that, but it does.

At the peak of my affliction, in high school and college, I only had about 4-8 migraines a year.  But, when I got one, it generally shut me down for the whole day.  The medicines I used back then usually only reduced the duration of the affliction.

The reader may find it interesting that once I started taking the tandem drugs: Zyprexa and Depakote, I no longer suffered any migraines.  I discovered that Depakote, sold by AbbVie Inc. (ABBV), is known to have anti-migraine effects.

I suffered from a very mild form of migraine occurrence, so Depakote may not be appropriate for many of those with the condition.

I knew someone for a brief time, whom I worked with, who had chronic migraine headaches, suffering from a migraine about every other day.  She definitely needed something a lot stronger than what I was on.  Eli Lilly & Co.'s (LLY) migraine medicine may find it's market for her and some of the 30 million migraine afflicted adults in the U.S. still looking for a better solution.  I hope Lasmiditan is a success and makes Eli Lilly a lot of money.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Friday, September 11, 2020

The Emancipation of Job Creation

    President Donald Trump is doing well opening up many parts of the economy again.  However, due to certain Governors and other lesser political figures, much of the economy remains shut down.

I believe America deserves an Economic Liberation.  The President could sign an "Emancipation of Job Creation" executive order.  What this would do is to make it illegal for any Governor or lesser political position holder to ban: job creation, job performance, and the earning of any profit in the economic realm.

Being a Governor is not about going on a political power trip and flexing one's political muscle.  Man has a Right to Economically Work.  And, my executive order proposal would put this Freedom in writing.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Tuesday, September 1, 2020

Pay It or Delay It

    A company has the right to set any price for it's products.  In the case of medicine, there is a patent mechanism that dissolves an inventive company of it's exclusivity of sales after a set number of years.

Too many people seek to cheat their way out of this system.  To them, I say, "Pay it or delay it".

I was coerced into buying a drug that Eli Lilly & Co. (LLY) sold at a price range of $600 - $900+ per month.  I worked for the money that went to the pharmaceutical company.  Then after 5 years, I got a job promoting Eli Lilly & Co. (LLY) in exchange for samples.  The terms of the deal were that I was to spend at least half of my non-sleeping, non-working time trying to find any way I could to promote the company and make it's value rise.

I learned everything I could about the company and Big Pharma.  I became a hawk on the lookout for any political story that could develop into harm to Eli Lilly.  And I read 25 books in the fields of medical history, economics, politics, and biographies of great doctors.  I even scoured Amazon and found 3 books specifically about Eli Lilly & Co. (LLY).

Eventually Eli Lilly's Zyprexa drug went off patent.  However, I didn't want to stop.  Part of me wanted the assurance that Eli Lilly & Co. (LLY) had gotten a good deal from our arrangement.  And, another part was just having too much fun.  I stayed with my studies and blogging--trying desperately to keep the secret of an expired patent under wraps.  I remember seeing a post-patent Quarterly Report and wondering if perhaps 10 million in Zyprexa sales was caused solely by me.

After about a two year off-patent victory lap, I made peace with my pro-Lilly conscience and finally abandoned my intensive promotional efforts.  For years, I pursued other things: science, philosophy and fiction.  However, it was not uncommon for me to wonder at times, what it would be like to return to Lilly Fuel.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Policy for Current and Future Pandemics

    It has been said that the U.S. was unprepared for the Coronavirus Pandemic because our government's cupboards were barren.  America should learn from that mistake now, as well as for several years into the future when Covid will no longer be a problem.

But, there are other pandemic threats beyond the Coronavirus--one specifically that is already taking a significant biological toll.  Antimicrobial Resistance, or AMR, is slowly growing into a Covid sized pandemic.  It is estimated that currently, about 30,000 Americans die from AMR each year.  And, if not stopped, 10,000,000 people globally may die in the year 2050.

What AMR entails is the mutation of biological entities that anti-biotics neutralize, such as bacteria, that render the anti-biotics unable to do their function.  Since so many medical procedures depend on effective anti-biotics, this poses a major problem.

Recently, about 20 Big Pharma and Biotech Companies have contracted a total of about 1 billion dollars to research and develop new anti-biotics.  It is unfortunate that I have to point out that if the FDA or other government organizations get in the way of this AMR Action Fund they will be sentencing tens of thousands of Americans to death.

Let's learn from Covid, develop a Capitalist economic policy, not destroy the future of medicine by denying companies profit, and use a reasonable amount of resources to fill the medicine cabinet so the cupboards will not be barren next time around.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Wednesday, August 26, 2020

I Believe Trump Will Stand Against Socialism

I don't know if my readers noticed; but I haven't written in this blog for about a month.  My last post explained that I was beginning to get cold feet concerning Big Pharma and Biotech.  Shortly after I wrote that, I saw a speech where President Trump basically said that he only cares about reducing prices that drug customers pay.  And, he doesn't care at all about Big Pharma and Biotech, except to the extent that they keep on inventing new medicine.

That really scared me!  You see, so much of my strategy since March has been focused on trying to influence and bring about a Capitalist policy that the Trump Administration would embrace.  But, to hear Trump so brazenly endorse socialist price fixing, and, what's more, that he doesn't give a damn about Capitalism in medicine was very alarming.

The next day I sold all my shares in Eli Lilly & Co. (LLY).  The stock hadn't crashed or anything; so I walked away with a decent profit for Covid times.

To summarize a long chain of thinking that I went through after that day; a couple of weeks later, I heard a radio advertisement speaking out against the administration's "socialized price fixing".  It sounded like it was sponsored by a Big Pharma organization.  And, it specifically did not talk about Trump as though he was an enemy.  The script went something like: "Let our guy know that America does not want socialized price fixing".  Then, about a week ago, I saw a short Trump ad on his Twitter account tally through several "pro-Trump" selling points.  Unfortunately, one of them was government-forced, low drug prices.  However, on Monday, I was going through Twitter again; and I saw a new Trump advertisement.  This was a much longer one that included all the major, supposed "pro-Trump" selling points in the last ad--except...the socialized price fixing part was gone!

There was a very famous speech; I think it was one of The State of The Union speeches, where President Trump said: " America will never be a socialist country.".  What I think happened over the last month has been a clash of contradicting philosophies.  Here Trump had already declared he won't stand for socialism.  And yet, he made a mistake of declaring socialist price fixing.  There is no way to keep one's "word" in this situation.  The contradiction has already been made.  The only question is which way to go--socialism, or not socialism.

I'm hedging on a restored Capitalist Trump.  Early in the week, I reinvested in Eli Lilly & Co. (LLY).  Expect to see more blogs in Lilly Fuel in the coming weeks.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Sunday, July 26, 2020

A Capitalist Environment in Medicine

I am happy to see that President Trump is back addressing America with frequent speeches and news conferences.  In the first couple months of Covid, I probably followed 90% of Trump's direct lines to his constituents.  And, I agreed with far more of what he said than you would find if you compared me to most prominent Objectivists. Unfortunately, my support just hit a snag.

A couple days ago, President Trump came out for government price fixing of drugs and pharmaceuticals.  This is very disappointing to me, as I thought the President was beginning to see how useless and damaging heavy regulation is in the drug industry and biotech.

I don't want to make an enemy of President Trump, because I think he's the best thing we've got, but, trading deregulation for socialist price fixing is not a political tool to try to get more votes from high-priced medical purchasers.  Leaving price freedom to the companies, and removing regulation on drug R&D should be done because they are the right things to do.

Paul Wharton
Objectivist Capitalist Medicine Promoter

Tuesday, June 9, 2020

Lilly's Ambition to Extend its Legacy in Neurology

Big Pharma Eli Lilly & Co. (LLY) just announced yet another joint venture with a promising Biotech business: Evox Therapeutics, based in Oxford, England.  This time the focus is Neurology.

Eli Lilly currently does not have much of a neurological portfolio.  However, its history is rich in it.

Prozac was invented by Eli Lilly & Co. (LLY), and soon swept the world as the first highly effective drug for depression.

Zyprexa was extremely profitable until it went generic almost 10 years ago.  It took in sales of over 5 billion per year.

I buy and use the Eli Lilly drug that was known as Zyprexa along with Depakote that was sold by AbbVie Inc. (ABBV).  I've been injected with most of the drugs in the psychiatric arsenal.  And, Zyprexa and Depakote are the only ones I tolerate.

While a new drug would have to have a really good reputation to get me to try it, I would still love to see Eli Lilly & Co. (LLY) extend its proud tradition in neurological medicine.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Tuesday, June 2, 2020

This is What Free Market Pharma Can Do

Before the Coronavirus Pandemic, if a pharmaceutical company wanted to: develop, test, and win "approval" from controlling, government regulatory departments to sell a medicine, the process could typically take about 15 years.

Then Covid 19 hit.  It was contagious--a very deadly flu that spread around the whole world.  There was no known cure, or any treatment at first.  Finally, America woke up.  The United States government, led by President Donald Trump, slashed red tape, drastically rolled back regulations, and even restrained many government departments from getting involved at all.

On March 12th of this year, Eli Lilly & Co. (LLY) began a collaboration with AbCellera Biologics Inc. to co-develop antibody therapies for Covid 19, where Big Pharma, Eli Lilly, assumed the responsibility to manufacture and market the resulting medicine.

Just 81 days later, the product of private effort--a selected antibody that would have taken perhaps a decade to advance before--is entering human trials to determine its safety and tolerability.

June 1st marks a milestone in the history of medicine.  Instead of medical companies being overly worried about being blamed if something goes wrong, and bureaucrats depending on infallibility for their careers, finally in an atmosphere of reasonability: scientists, businessmen, and stockholders are liberated to advance one of the most important products of mankind.  Watch Eli Lilly & Co. (LLY).  This is what Free Market Pharma can do.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Sunday, May 31, 2020

Lilly to Market Groundbreaking Alzheimer's Diagnostic Drug

Eli Lilly & Co. (LLY) has gained the green light to market Tauvid which can be used to identify neurofibrillary tangles formed within brain neurons in people with Alzheimer's Disease.  This groundbreaking method using Eli Lilly & Co.'s (LLY) drug is very significant, as the tau tangles previously lacked any way to identify the Alzheimer's characteristic in living individuals.

Alzheimer's is a medical disease of which I have some knowledge.  Second Renaissance Books, the bookstore set up by Ayn Rand herself, sold a book about the condition which I read that was nearly 250 pages.

Eli Lilly & Co. (LLY) has been working on Alzheimer's Disease for a very long time.  Despite this new diagnostic tool, their still remains no medical treatment for Alzheimer's.  However, Lilly's tau-based diagnosis could become widely used.

I googled Alzheimer's population statistics and found that 10% of Americans age 65 and older have Alzheimer's Disease.  And, 32% of those age 85 and older have Alzheimer's.

Eli Lilly's test to alert families about a relative who is beginning to get Alzheimer's Disease may develop a high demand.  And, when one multiplies that demand by the prevalence in the population of America, and the entire World, Eli Lilly & Co.'s (LLY) diagnostic drug could prove lucrative, indeed.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Thursday, May 28, 2020

Covid 19 Profit (x9)

Last Friday, the Eli Lilly & Co. (LLY) partner in the fight against Covid 19, AbCellera Biologics Inc., announced that the two medical companies have expanded their collaboration to go beyond the effort to battle the virus.  AbCellera is unique in their scientific minds, method, and equipment that can be marshaled to discover useful antibodies as a powerful weapon against disease.  But now, not only will Eli Lilly & Co. (LLY) be advancing towards a Covid 19 product, there is a deal for possibly 9 medicines to counter different medical issues that could prove equally lucrative.  Through trying a novel antibody identification approach, Eli Lilly & Co. (LLY) believes it has stumbled upon a wealth of opportunity that can be the mother load of future profits.

Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific officer and president of Lilly Research Laboratories, stated, "AbCellera's capabilities and team are extremely impressive and we are proud of the progress we've made together thus far."

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Saturday, May 9, 2020

Lilly's COVID 19 Candidate Fast Tracked

The Eli Lilly & Co. (LLY) drug, Olumiant (also known as baricitinib) has been fast tracked to a final study before use to fight COVID 19.  Lilly's baricitinib, already used to treat rheumatoid arthritis, belongs to a class of weapons against COVID 19 that have the advantage of a safely proven track record in the human body.  President Trump pushed for the first two of these, which he added to the American arsenal.  And, just last week, a Gilead Science (GILD) drug, remdesivir, became the third.  However, Lilly's baricitinib is already in tests to find out if it will be the fourth, and, in fact, could be used as a tandem drug combination with Gilead's medicine.

I am pleased that government drug regulatory departments are, for the most part, getting out of the way.  After all, it isn't just the non-paying, drug-injected welfare cases that may suffer if an under-tested drug has harmful side effects.  Those who have to wait and die before the government lets a pharmaceutical company sell it's product pay a big price too.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Tuesday, May 5, 2020

Lilly Battles Virus With Another Deal

Eli Lilly & Co. (LLY) has announced yet another collaboration with a biotech company to battle COVID 19.  This time it is with Junshi Biosciences.

The two companies will strive to co-develop therapeutic antibodies for treatment and prevention of COVID 19.

As President Trump deregulates biotechnology and pharmaceuticals in response to the greater and greater realization that the economy will only recover in the short run if the long run medical solution is no longer in the "long run", more and more companies are diverging resources and effort towards the promise of a Capitalism friendly business environment when this crisis is over with.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Sunday, April 26, 2020

Eli Lilly Up 24% Since March 18th



On Wednesday, March 18th, I invested in Eli Lilly & Co. (LLY) after being out of the name since 2016.  That night, I wrote my first blog in Lilly Fuel in about five and a half years.

I reinvested in Eli Lilly & Co. (LLY) when it was at $131.06 per share.  On Friday, April 24th, Eli Lilly & Co. (LLY) closed at $162.93 per share.

That gives me a more than 24% profit in only 37 days!

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Friday, April 17, 2020

Mike Pence and Eli Lilly & Co. (LLY)

The Vice President of the United States of America is Mike Pence.  He is a Hoosier from the state of Indiana, and was in fact a Congressman and Governor of that state before being invited by Donald Trump to be his running mate.

Eli Lilly & Co. (LLY) is based in Indianapolis, Indiana.  It is a Large Cap business with about 34,000 employees--making it the third biggest company in Indiana.

I have been aware of Mike Pence since his gubernatorial days when I would cover a lot of news about Indiana in the process of following Eli Lilly & Co. (LLY).  When Pence was running for President in 2016, before he dropped out and Trump picked him up, I remember a speech in which he described himself as: a Christian, a Conservative, and a Capitalist.  While I don't agree too much with the first two, it is notable that a man who values Laissez-Faire, Free Market Capitalism could be a powerful force for profit in the economy.

Despite my pre-familiarity, unfortunately I don't think that most Americans knew that much about Mike Pence, until his COVID 19 Response Coordination role.  If history is any guide, it is very common for a Vice President to be the candidate for the Presidency after the President's lame duck years are set to expire.

So, with Eli Lilly & Co. (LLY) racing with several projects to battle COVID 19, especially at their ground zero, in Indianapolis, Indiana, I think investors should consider the "Mike Pence factor", in deciding whether or not to invest further in Eli Lilly & Co. (LLY)--especially in the long run.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Tuesday, April 14, 2020

Abbott Labs: Another Lilly

I was very pleased today to hear President Trump mention Eli Lilly & Co. (LLY) during his news conference.  Another company that he said among the many captains of industry he referred to was Abbott Labs.  Abbott Laboratories (ABT) is in fact one of the most mentioned companies by Trump in his nearly daily news conferences.

Just as perhaps millions of Americans may one day be able to thank Abbott Laboratories (ABT) for their pioneering technology in the field of COVID 19 testing, I too have a debt to pay them.

You see, back more than 20 years ago when I started buying the Eli Lilly & Co. (LLY) product, Zyprexa, I was encouraged to stay with a medicine that Abbott Laboratories (ABT) had developed called Depakote.  Apparently, the two medicines have a symbiotic effect, as it is called in biology, meaning neither one alone is as effective by itself as they are together--where they equal more than the sum of their parts.

When I decided to start blogging for a maker of medicine I was buying, I chose to single out Eli Lilly & Co.'s (LLY) Zyprexa, at first, mainly because it is the more powerful of the two drugs.  And later, when I created my own blog, I had already been blogging for years in exchange for an unofficial deal to receive medicine through the doctor.  Anyone who goes back and reads the advocacy and ideas that I produced would be dishonest with oneself if it wasn't agreed that Eli Lilly & Co. (LLY) got a good deal out of it.

Abbott Laboratories (ABT) sold it's Depakote at a much lower cost than Eli Lilly sold it's Zyprexa.  I did get a $50 discount through a company rebate that Abbott sponsored for a while.  But, it really paid off more to focus on Lilly's better arrangement.

About 8 years ago, Abbott Labs spun off it's pharmaceutical wing into a separate company that became known as AbbVie Inc. (ABBV).  Abbott Laboratories (ABT) remained as mainly a medical device company from which it already did a lot of business.  So, my Depakote medicine then fell under the jurisdiction of AbbVie Inc. (ABBV) to which I started to give all my thanks when I mentioned it.  However, with Abbott Labs in the big news, I think it is necessary to remind all my readers where Depakote started.

Paul Wharton
Special thanks to Abbott Laboratories (ABT) and Eli Lilly & Co. (LLY) for inventing the fuels of my mind

Monday, April 13, 2020

Lilly Advances Antibody Therapy Testing

Eli Lilly & Co. (LLY) is on a fast track to develop new therapeutic medicines to fight COVID 19.  On Friday, the company announced that it will, "advance LY3127804, an investigational selective monoclonal antibody against Angiopoietin 2 (Ang2), to Phase 2 testing in pneumonia patients hospitalized with COVID-19 who are at a higher risk of progressing to acute respiratory distress syndrome (ARDS)."

Combating ARDS is very significant--as it is respiratory issues that are killing so many COVID 19 patients.  The demand for a therapy against this problem can be seen by the enormous focus on building and supplying enough ventilators.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Existing Lilly Drug in Two Month Trial

President Trump advocated for and promoted two drugs for COVID 19 that were already on the market, but used for different ailments.  While America, and indeed the World, cannot worry too much about new drug proposals that do not have a proven record of safe side effects, it is helpful to look at an existing market's customers to see how safe drugs turn out to be.

The pharmaceutical company, Eli Lilly & Co. (LLY), believes it owns a third, already marketed drug, that can have a positive effect against COVID 19, even though it is usually used against rheumatoid arthritis.  The medicine, called OLUMIANT (otherwise known as baricitinib), will be evaluated in a study to measure efficacy that, unfortunately, is expected to conclude in about two months.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Saturday, April 11, 2020

Infrastructure: An Objectivist Approach

The biggest long-term danger to the U.S. economy is more inflation and government spending.  I have been watching a lot of President Trump's news conferences; and I have seen the following chain of thought more than once:

(1) America spent 7 to 8 trillion in the Middle East wars; and that was okay.
(2) So, what difference is it to spend 2 trillion more and earmark a lot of it for infrastructure?

My argument against that type of spending is that America should have found a way not to spend money in foreign wars, or, at least, to have spent less--especially on foreign nation building.  And, in regard to domestic infrastructure, civil property, such as roads and bridges, don't belong in the public sector anyway.  It should all be private property.

So, as an Objectivist, the following is our approach to dealing with crumbling public roads, public bridges, public airports, etc....

All government infrastructure (excluding: military, police, judicial, diplomatic, and treasury assets) should be identified.  The five government sectors I just mentioned are excluded because they are the five legitimate sectors of government, according to Objectivism.

Once it is identified what is left, a system of division should be finalized (perhaps according to different state counties).  Then, it should be announced that an auction of all public, non-legitimate sector, infrastructure is to be scheduled for a not too distant date.  Some time should be allowed, for bidders to investigate what they would be buying.

When the auction day comes, it should be conducted with standard auction rules.  After it ends, and the proceeds are completely compiled, the total of each income tax payer's taxation over the years divided by the total intake of government income taxes over the years (which creates a fractional number for each individual), should be assigned to each tax payer.  The total monetary intake from everything auctioned should be multiplied by each individual's refund fraction.  Then all the historic taxpayers get that amount of money back.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Thursday, April 9, 2020

Eli Lilly's Diabetes Play

I was an investor in Eli Lilly & Co. (LLY) throughout many of the Obama years.  My stock profit from the company amounted to more than $10,000.  However, shortly before Trump's 2016 victory, I sold my stock and moved on to other endeavors.  I want to take the opportunity in this blog to announce that I have reinvested in the company.  I will be posting my ideas in the blog: "Lilly Fuel", which I hadn't written in since 2014.

One of the reasons I abandoned my Eli Lilly investment in 2016 was a philosophical one.  You see, Eli Lilly is an extremely generous company.  While I have benefited enormously over the years when I moved on from being a full price, self-pay customer for 5 years, to having an unofficial agreement of accepting samples in exchange for my dedication to spend half, or more, of my non-working, non-sleeping time being an advocate and blogger for Eli Lilly & Co. (LLY), I often had the nagging guilt that Lilly's element of altruism was holding me back financially.

Well, that being said. I want to take the time to applaud Eli Lilly & Co. (LLY) for a very morally, self-interested move.  Since I have been deeply involved with the company, Lilly has evolved more and more into a diabetes business.  While I'm not very knowledgeable of that disease, the company markets 5 major diabetes brands.  And, Eli Lilly is in fact one of the biggest insulin producers in the world.

So now, in the spirit of profitability, Eli Lilly & Co. (LLY) has lowered many of their diabetes prescriptions to $35 per month.  COVID 19 unemployment has devastated so many diabetics financially that I see it as a customer loyalty move.  Its simple economics.  With so many individuals out of work, their personal money supply had decreased, thus, unless Lilly's price is scaled back, demand for Lilly's products will be reduced.

The other philosophical stand by Eli Lilly & Co. (LLY) that is highly virtuous I quote from a Reuters press release:

"...patients with government insurance such as Medicaid, Medicare, Medicare Part D or any State Patient or Pharmaceutical Assistance Program are not eligible..."

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Monday, March 30, 2020

Check This, Communists!

I want to state for the record that I am voting for Trump in November.  No matter what missteps he makes, he will never be anywhere near as bad as the Democrat Party has become.  But, that being said, through the many, many hours of my coverage on COVID 19, I supported, or at least understood most of what President Trump did, until: he, the Fed, and most of Congress ganged up to inflate the dollar and/or tax Americans by taking $6,200,000,000,000.00.

That made me extremely angry.  Unlike most irresponsible Americans, who spend all their money every two weeks, or go into debt.  I have held onto a sizable savings for about 16 years--ever since my businessman grandfather's stock which he had passed on to me was liquidated.  Throughout all of the Obama years, I almost always worked more than 40 hours / week--sometimes as much as 70 hours / week.  During one period, I worked so much that the higher management went into the system and tracked my work record where I literally worked every single day for 6 months!  What broke my streak was a utility problem in one of the stores that sent me home when I arrived for the assigned shift.  Some can say I'm somewhat rich because of that 2.5% stock holding in a Florida citrus company.  But, I worked to stay where my grandfather put me.  And, in fact, through all the Obama years, I increased my net worth.

The Obama experience should have taught every American to work and save.  When I hear the Trump Administration or Republicans in Congress complain that poor Americans are financially suffering through "no fault of their own", the question that comes to mind if a laid off employee won't just go out and find whatever jobs are still available is, "Didn't you learn anything from the Obama Era?"  If one just looks at what Obama did to America, every individual from 2016 onward should have been working in overdrive to: pay any debts, build up a savings, and restrain oneself from putting it all into the stock market.

So, being an American who has learned and is applying the lessons taught by that Terrible Destroyer, I am: continuing to work in overdrive (if you count my intellectual, second job, at home).  I have no debts.  I am working whatever hours I can get in my cash job at Domino's.  And, I am tracking the stock market where I only had about half of my savings when the COVID 19 Pandemic began.

However, what this $6,200,000,000,000.00 spending does to my savings is to destroy a huge part of it.  Government and different schools of thought try to convince us to rationalize accepting a fraction of someone else's capital that has been taken or diminished.  There's the, previously mentioned, "No fault of your own." line.  There's the, "You have been paying into the system all your life..." line.  Or, unfortunately for me (because I'll probably get hell from the Objectivists for this) there's the, "It's OK to not let yourself be as much of a victim, so accept welfare like Ayn Rand did."

But, you see, I am a maker who refuses to be a taker.  However, I have a different view than those welfare peddlers who are either going to get a hook in me or reel back the lure intact.  That Treasury Department check that will soon be in the mail will neither be cashed by me, nor returned so the Communists' hands can run the precious gems and rice grains through their fingers.  The check will be framed and put on an Objectivist book shelf in my living room.

I have no claim on the check.  Perhaps, there is some tens of billionths way to rationalize a speck from a lake of gold that would be mine.  But, if you think of it, a check of that amount is really Jeff Bezos's (the richest man in the world).  If I could have a way to really believe that Mr. Bezos would be receiving his money, I would gladly endorse and give him his check.

In the meantime, I am concerned for Mr. Bezos's personal recreation funds.  Perhaps I can set up a charity drive that will match his check with more money to meet his non-discretionary activities.  But, until the day comes, when and if my shelf trophy can reach it's rightful owner, that symbol of outrageous taxation and dollar inflation will sit in my home waiting.  So, I say to the government...

Check this, Communists!

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Sunday, March 22, 2020

It's Obama's Fault

Think back to family finances before the stock market dive when it became apparent that Obama was going to assume America's highest political office.  It wasn't entirely George W. Bush's fault that the market began to decline in the latter half of 2008.  Do you remember the kind of things Obama was telling us?

America was now going to be so prosperous

Spend your money and enjoy yourself

The more you spend, the more it will boost the economy

Before Obama, most Americans had a significant savings.  The middle class often had a sizable "nest egg".  But, by the time Obama left Washington, there were millions of Americans living "paycheck to paycheck"; and many "nest eggs" were gone.

The COVID-19 response is going to result in incredible economic strain and hardship that I think is not yet understood by most Americans.  I desperately hope that a Democrat does not win the Presidency in November--as that would completely destroy us.  But, whatever a Donald Trump Presiding outcome, I argue that the middle class and "paycheck to paycheck", pre-COVID-19 Americans are not going to suffer the worst of times strictly because of the virus.  They were encouraged to spend by Obama.  Their savings was eroded by Obama.  And, indeed, their hardships are Obama's fault.

Paul Wharton

Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Friday, March 20, 2020

Big Pharma Teams Up With Biotech

A trend I have been noticing in the news is the announcement of joint ventures of Big Pharma with Biotech.  Biotech companies have the most to offer as far as science goes, while Big Pharma not only has plenty of science to contribute, but also a massive development, manufacturing and distribution infrastructure.

About three weeks ago, the privately held, relatively new company: AbCellera Biologics Inc., based in Vancouver, British Columbia, obtained blood samples from one of the first COVID-19 recovered patients in the United States.  AbCellera screened over 5 million immune cells to discover functional antibodies that helped recovery and neutralization of the disease.

On March 12th, Eli Lilly & Co. (LLY) signed an agreement with AbCellera to co-develop antibody therapies for COVID-19.  The companies will equally share initial development costs, where upon Eli Lilly & Co. (LLY) will be responsible for the costs of further development, manufacturing, and distribution of the products.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

Wednesday, March 18, 2020

Lilly Joins the Fight in Indiana

One of America's biggest pharmaceutical businesses is Eli Lilly & Co. (LLY), based in Indianapolis, Indiana.

Yesterday, they announced a philanthropic project to fight the spread of COVID-19, starting in their home state.  Through collecting samples from affected individuals, they will apply their extensive medical laboratories to try to discover treatments, vaccines, and cures.

One of the most remarkable aspects of this Eli Lilly & Co. (LLY) initiative is the fact they have announced  that their expansive testing plans will be entirely self-funded.  No money will be accepted from: government agencies, hospitals, insurance companies, patients, and the FDA.

While some observers may accuse Eli Lilly & Co. (LLY) of being altruistic in their initiative, I disagree for two reasons:

First, Eli Lilly & Co. (LLY) has the scientific minds and equipment which are uniquely situated to make a difference in the world's battle against it's current nemesis.  If Eli Lilly & Co. (LLY) were to do nothing, the virus would sweep through Indianapolis, and all of Indiana, wiping out much of the economy on which the company and it's employees depend.

Second, there is a price to pay for accepting money or capital from government.  The saying, "Nothing is free.", is certainly true.  Years ago, a government hospital insisted on setting me up with "free" Zyprexa; but, as I quickly found out, I had to see a public doctor who wouldn't prescribe it, and instead wanted me to "take" an inferior, less expensive drug.  I was also forced to go to something they called a "group" once a week, that entailed sitting in a room with a public county official and listening to the dregs of the neighborhood discuss their problems.  My "free ride" ended when I went out and found a private doctor who would prescribe Zyprexa (for which I paid full price for 5 years to buy)

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind